Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . November 24th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Liver Transplantation - Living liver donors increase the risk for cholestasis in graft recipients
Occupational Health - Aerosols generated during dental debonding may transmit hepatitis B infection
Hepatitis C - Hepatitis C virus infection flourishes apart from dendritic cell impairment
Lipid Studies - Cholesterol is required for hepatitis B surface antigen secretion
Proteomics - Small molecule inhibitory compounds keep HCV E2 from binding to CD81
Transplant Medicine - Donor-transmitted malignancy highlights a need for organ procurement vigilance
AIDS Co-infections - Data: Hepsera associated with sustained reductions in hepatitis B virus
Biotechnology - Liver cells cultured in a bioreactor release infectious hepatitis C virus
Cirrhosis - Hepatitis C virus reinfection speeds rejection after liver transplantation
Genomics - Antisense oligodeoxynucleotides targeting Hsp60 block human HBV replication
HIV/AIDS Therapy - Studies on tenofovir DF therapy for HIV infection reviewed
Health - Pegasys more effective than current hepatitis B treatments in new study
Hepatitis - Histamine dihydrochloride prevents alcohol-induced harm to the liver
Hepatitis B - Data suggests investigational drug suppresses hepatitis B most effectively
Hepatitis B - Prophylactic therapy makes renal transplantation safe for hepatitis B patients
Hepatitis C - New hepatitis C therapy may benefit patients with normal ALT levels
Hepatitis C - Positive data reported on IDN-6556 for liver impairment in HCV patients
Hepatitis C - Positive interim results of phase I/II clinical trial of Albuferon reported
Hepatitis C - Positive results reported from Infergen/ribavirin combination therapy trial
Hepatitis C - Protease inhibitor shows in vitro antiviral activity in hepatitis C
Hepatitis C - Research findings suggest new hepatitis C drug's potent antiviral activity
Hepatitis C - Study investigates Pegasys and Copegus in African Americans
Hepatitis C - Study shows benefits of therapy in previously under-treated patient population
Hepatitis C - Triple therapy shows early virologic response for hepatitis C non-responders
Hepatology - Hydrangeae Dulcis Folium extracts suppress liver injury in rodent models
Immunology - Higher steroid doses improve liver function during acute rejection episodes
Liver Cancer - Green tea polyphenols modulate excretion of cancer biomarkers
Liver Damage - Company presents preclinical data on liver regeneration
Liver Disease - Interleukin 10 increases viral burden but reduces inflammation in HCV patients
Market Analysis - New offerings will be launched in hepatitis B drug market
Oncology - Several risk factors are associated with hepatocellular carcinoma metastasis
Transplant Medicine - Excellent survival rates seen for liver cancer patients undergoing transplant
Viral Genomics - Interferon suppresses HCV via cytopathic and noncytopathic means
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
